Skip to main content

Table 3 Patient demographics and indication for colonoscopy

From: Effect of bowel preparation volume in inpatient colonoscopy. Results of a prospective, randomized, comparative pilot study

Ā 

Large volume preparation (nĀ =ā€‰9)

Medium volume preparation (nĀ =ā€‰8)

Low volume preparation (nĀ =ā€‰8)

Total

(nĀ =ā€‰25)

P-value

Female gender, n (%)

3 (33.3%)

3 (37.5%)

2 (25.0%)

8 (32.0%)

0.86

Age (years)

ā€ƒMean (Ā±SD)

70.8 (Ā±12.33)

62.1 (Ā±17.46)

66.5(Ā±19.79)

66.6 (Ā±16.34)

0.57

ā€ƒRange

51ā€“86

32ā€“85

35ā€“84

32ā€“86

BMI (kg/m2)

ā€ƒMean (Ā±SD)

29.1 (Ā±4.21)

25.3 (Ā±3.67)

29.8 (Ā±7.59)

28.2 (Ā±5.57)

0.25

ā€ƒRange

22.9ā€“35.7

18.2ā€“29.8

23.2ā€“45.6

18.2ā€“45.6

Diabetes, n (%)

2 (22.2)

2 (28.6)

2 (25.0)

6 (25.0)

0.96

Chronic constipation, n (%)

1 (11.1)

1 (14.3)

2 (25.0)

4 (16.7)

0.73

Neurologic disease, n (%)

0

Lewy body dementia: 1 (12.5)

Paraplegia: 1 (12.5)

2 (8)

0.36

Use of medication that may cause constipation

Opiate: 2 (22.2)

Opiate: 1 (12.5)

Opiate + Carbidopa: 1 (12.5)

Opiate: 2 (25)

Nortryptiline: 1 (12.5)

Opiate: 5 (20)

Opiate + carbidopa: 1 (4)

Nortryptiline: 1 (4)

0.58

Indication for colonoscopy

ā€ƒAbnormal imaging

0 (0.0%)

1 (12.5%)

0 (0.0%)

1 (4.0%)

0.71

ā€ƒDiarrhea

1 (11.1%)

2 (25.0%)

2 (25.0%)

5 (20.0%)

ā€ƒHematochezia

6 (66.7%)

3 (37.5%)

3 (37.5%)

12 (48.0%)

ā€ƒIBD

0 (0.0%)

0 (0.0%)

1 (12.5%)

1 (4.0%)

ā€ƒMelena

1 (11.1%)

0 (0.0)%

1 (12.5%)

2 (8.0%)

ā€ƒAbdominal pain

0 (0.0%)

1 (12.5%)

0 (0.0%)

1 (4.0%)

ā€ƒAnemia

1 (11.1%)

1 (12.5%)

1 (12.5%)

3 (12.0%)